Simply Assessing Vascular Health
What if you could identify high risk patients at the earliest stage
of their cardiovascular disease - would you treat them differently?
The EndoPAT – the only FDA-cleared test for the non-invasive assessment
of Endothelial Dysfunction (arterial health); clinically proven by leading cardiologists
through prestigious peer-reviewed studies as a valuable tool in cardiovascular
risk stratification beyond commonly used tests.
The only FDA-Cleared device indicated for the diagnosis of Endothelial Dysfunction. Accurate & Reproducible